Article Cited by others

ORIGINAL ARTICLE

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Cai Xiang, Tian Ye, Wu Tao, Cao Chen-Xi, Li Hong, Wang Kun-Jie

Year : 2014| Volume: 16| Issue : 1 | Page no: 146-152

   This article has been cited by
 
1 Pubertal testis volume, age at pubertal onset, and adolescent blood pressure: Evidence from Hong Kongæs “Children of 1997” birth cohort
Man Ki Kwok,Gabriel M. Leung,C. Mary Schooling
American Journal of Human Biology. 2017; : e22993
[Pubmed]  [Google Scholar] [DOI]
2 Testosterone and Cardiovascular Disease
Robert A. Kloner,Culley Carson,Adrian Dobs,Stephen Kopecky,Emile R. Mohler
Journal of the American College of Cardiology. 2016; 67(5): 545
[Pubmed]  [Google Scholar] [DOI]
3 Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study
A. A. Yassin,J. Nettleship,Y. Almehmadi,M. Salman,F. Saad
Andrologia. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
4 THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study
Giovanni Corona,Vito A Giagulli,Elisa Maseroli,Linda Vignozzi,Antonio Aversa,Michael Zitzmann,Farid Saad,Edoardo Mannucci,Mario Maggi
European Journal of Endocrinology. 2016; 174(3): R99
[Pubmed]  [Google Scholar] [DOI]
5 In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction
Fouad Aoun,Anthony Kallas Chemaly,Simone Albisinni,Marc Zanaty,Thierry Roumeguere
Asian Pacific Journal of Cancer Prevention. 2016; 17(1): 1
[Pubmed]  [Google Scholar] [DOI]
6 Interaction of sex steroid hormones and obesity on insulin resistance and type 2 diabetes in men: the Third National Health and Nutrition Examination Survey
Ji Li,Hong Lai,Shaoguang Chen,Hong Zhu,Shenghan Lai
Journal of Diabetes and its Complications. 2016;
[Pubmed]  [Google Scholar] [DOI]
7 Spironolactone and glucose metabolism, a systematic review and meta-analysis of randomized controlled trials
Jie V. Zhao,Lin Xu,Shi Lin Lin,C Mary Schooling
Journal of the American Society of Hypertension. 2016;
[Pubmed]  [Google Scholar] [DOI]
8 Glucose-6-Phosphate Dehydrogenase Deficiency and Physical and Mental Health until Adolescence
Man Ki Kwok,Gabriel M. Leung,C. Mary Schooling,Junwen Wang
PLOS ONE. 2016; 11(11): e0166192
[Pubmed]  [Google Scholar] [DOI]
9 Associations of Cardiovascular Risk Factors with Carotid Intima-Media Thickness in Middle-Age Adults and Elders
Tzu-Wei Wu,Chung-Lieh Hung,Chun-Chieh Liu,Yih-Jer Wu,Li-Yu Wang,Hung-I Yeh
Journal of Atherosclerosis and Thrombosis. 2016;
[Pubmed]  [Google Scholar] [DOI]
10 Debate: Testosterone Therapy Reduces Cardiovascular Risk in Men with Diabetes. Against the Motion
C. Mary Schooling,Lin Xu,Jie Zhao
Current Cardiovascular Risk Reports. 2015; 9(5)
[Pubmed]  [Google Scholar] [DOI]
11 Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials
Mathis Grossmann,Rudolf Hoermann,Gary Wittert,Bu B. Yeap
Clinical Endocrinology. 2015; 83(3): 344
[Pubmed]  [Google Scholar] [DOI]
12 Effects of testosterone replacement on glucose and lipid metabolism
Isabel Errazuriz,Simmi Dube,Ananda Basu,Rita Basu
Cardiovascular Endocrinology. 2015; 4(3): 95
[Pubmed]  [Google Scholar] [DOI]
13 Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men
Aksam Yassin,Yousef Almehmadi,Farid Saad,Gheorghe Doros,Louis Gooren
Clinical Endocrinology. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
14 Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management
Shin-ichi Hisasue
International Journal of Urology. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
15 Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both
Shawn Riser Taylor,Lindsy M. Meadowcraft,Bobbie Williamson
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2015; 35(8): 780
[Pubmed]  [Google Scholar] [DOI]
16 Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review
Matthew L. Romo,Aileen M. McCrillis,Jennifer Brite,Dalicia Reales,Jennifer B. Dowd,C. Mary Schooling
European Journal of Clinical Investigation. 2015; 45(5): 475
[Pubmed]  [Google Scholar] [DOI]
17 Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men
Farid Saad,Aksam Yassin,Ahmad Haider,Gheorghe Doros,Louis Gooren
Korean Journal of Urology. 2015; 56(4): 310
[Pubmed]  [Google Scholar] [DOI]
18 Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence
Kitty Kit Ting Cheung,Andrea On Yan Luk,Wing Yee So,Ronald Ching Wan Ma,Alice Pik Shan Kong,Francis Chun Chung Chow,Juliana Chung Ngor Chan
Journal of Diabetes Investigation. 2015; 6(2): 112
[Pubmed]  [Google Scholar] [DOI]
19 Testosterone and obesity
D. M. Kelly,T. H. Jones
Obesity Reviews. 2015; 16(7): 581
[Pubmed]  [Google Scholar] [DOI]
20 Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
Giovanni Corona,Elisa Maseroli,Giulia Rastrelli,Andrea M Isidori,Alessandra Sforza,Edoardo Mannucci,Mario Maggi
Expert Opinion on Drug Safety. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
21 Adolescent testosterone, muscle mass and glucose metabolism: evidence from the ‘Children of 1997’ birth cohort in Hong Kong
W. W. Hou,M. A. Tse,T. H. Lam,G. M. Leung,C. M. Schooling
Diabetic Medicine. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
22 Testosterone supplementation and cardiovascular risk
Giovanni Corona,Mario Maggi
Trends in Cardiovascular Medicine. 2014;
[Pubmed]  [Google Scholar] [DOI]
23 Injectable testosterone undecanoate for the treatment of hypogonadism
Giovanni Corona,Elisa Maseroli,Mario Maggi
Expert Opinion on Pharmacotherapy. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
24 Marked Testosterone Deficiency-Related Symptoms May be Associated to Higher Metabolic Risk in Men with Low Testosterone Levels
Eduard García-Cruz,Asier Leibar-Tamayo,Javier Romero-Otero,Ignacio Asiaín,Albert Carrión,Roberto Castañeda,Laura Mateu,Pilar Luque,Oscar Cardeñosa,Antonio Alcaraz
The Journal of Sexual Medicine. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
25 Testosterone and cardiovascular disease
C. Mary Schooling
Current Opinion in Endocrinology & Diabetes and Obesity. 2014; 21(3): 202
[Pubmed]  [Google Scholar] [DOI]
26 Are We Testing Appropriately for Low Testosterone?: Characterization of Tested Men and Compliance with Current Guidelines
Rena D. Malik,Brittany Lapin,Chihsiung E. Wang,Justin C. Lakeman,Brian T. Helfand
The Journal of Sexual Medicine. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]

 

Read this article